AGTC Genomics Partners with GeneMind and Interscience to Accelerate Precision Medicine and Genomic Innovation in Southeast Asia
- cheeonnleong
- 5 days ago
- 2 min read
AGTC Genomics, one of the largest and most advanced genomics sequencing facilities in Malaysia, today announced a strategic partnership with GeneMind Biosciences and Interscience, marking a major milestone in advancing precision medicine, translational research, and genomic innovation across the region.
This tripartite collaboration brings together AGTC Genomics’ clinical-grade, high-throughput sequencing infrastructure, GeneMind’s advanced sequencing technologies, and Interscience’s regional scientific and research ecosystem, creating a powerful platform that bridges clinical diagnostics, biomedical research, and population-scale genomics.
Strengthening a Regional Genomics Powerhouse
AGTC Genomics operates one of the most comprehensive genomics laboratories in Southeast Asia, with capabilities spanning clinical diagnostics, translational research, and large-scale genome research. The laboratory is ISO 15189, ISO 17025, and CAP-accredited, underscoring its commitment to international standards of quality, accuracy, and regulatory compliance.
Through this partnership, AGTC further enhances its position as a regional reference genomics hub, supporting hospitals, clinicians, researchers, pharmaceutical companies, and academic institutions across Southeast Asia.
Comprehensive NGS Capabilities at Scale
AGTC Genomics offers more than 1,000 Next-Generation Sequencing (NGS)-based tests, covering a broad spectrum of applications, including:
Oncology: Comprehensive Gene Profiling (CGP), liquid biopsy, MRD monitoring, Multi-Cancer Early Detection (MCED), and etc
Rare & Inherited Diseases
Pharmacogenomics (PGx)
Microbiology & Metagenomics
Population Genomics & Multi-omics Research
These services are designed to support both routine clinical decision-making and advanced R&D, enabling faster translation of genomic insights into real-world healthcare impact.
“This partnership with GeneMind and Interscience represents more than technology collaboration—it is a strategic alignment to build sustainable, regionally relevant precision medicine infrastructure,” said Professor Dr. Chee-Onn Leong, Founder and CEO of AGTC Genomics. “With our scale, accreditations, and comprehensive test portfolio, AGTC is well-positioned to support both clinical excellence and long-term genomic research across Southeast Asia.”
Looking Ahead
The collaboration will focus on expanding sequencing capacity, enabling new clinical and research applications, supporting regional genome initiatives, and accelerating the adoption of precision medicine across public and private healthcare systems.
As Southeast Asia continues to invest in biotechnology, healthcare innovation, and population health, AGTC Genomics stands at the intersection of science, clinical impact, and scalable commercial opportunity.
About AGTC Genomics
AGTC Genomics is a leading precision medicine and genomics company in Southeast Asia, operating one of the region’s largest accredited sequencing facilities. With ISO 15189, ISO 17025, and CAP accreditations, AGTC delivers high-quality genomic diagnostics and research services to hospitals, researchers, and industry partners across Asia.
Comments